We are a bioincubator helping emerging biotechs decreasing their time to seed funding.

We have a growing commitment to engineering innovation that improves health industry efficiency.

latest news older news

MaSTerCell S.A. Announces Creation of a new Commercial Manufacturing facility for Cell & Gene Therapies

Masthercell announces today that it has signed a lease agreement for a 5.700 m² facility located in Gosselies. The new facility will become a state-of-the-art manufacturing and production site designed for late-stage and commercially-approved cell and gene therapy products. The commercial facility is expected to be operational in early 2021. Discover the press release here.

Read more

Graftys raises capital of €4.1M

Graftys, a world leader in resorbable bone cements, announces the completion of a €4.1M funding round, the development of its operations in Wallonia and the reinforcement of its French operations. Discover the press release here.

Read more
Learn more about our events all events next event


UMONS, ULB, ULg inaugurate the Mass Spectrometry Platform MS-QUANTA

The MS-QUANTA platform is dedicated to the identification and the absolute quantification o...

Read more